Macquarie Asset Management’s private equity fund is understood to have sealed the deal to acquire a 100% stake in Korean contract development and manufacturing organisation (CDMO) Genuone Sciences from local investor IMM Private Equity, according to sources familiar with the matter.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
